End-Stage Renal Disease (ESRD) Treatment Market Size, Trends, and Growth Strategies
The End-Stage Renal Disease (ESRD) treatment industry continues to exhibit robust growth driven by rising prevalence of chronic kidney diseases and advancements in renal replacement therapies. Increasing investments in innovative dialysis modalities and transplantation solutions have significantly altered the market dynamics, underscoring the expanding market opportunity in this critical therapeutic segment.
Market Size and Overview
The end-stage renal disease (ESRD) treatment market is estimated to be valued at USD 89.27 Bn in 2025 and is expected to reach USD 129.00 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.4% from 2025 to 2032.
https://www.coherentmi.com/ind....ustry-reports/end-st
